VentureBeat June 2, 2022
Jean Thilmany

Artificial intelligence and machine learning promise to transform healthcare across the board, but particularly through the use of precision medicine.

Precision medicine is often defined differently than the common phrase “personalized medicine,” which simply means tailoring treatments to the patient. Precision medicine, on the other hand, specifically applies machine learning to the genetic material of patients with less-common conditions. The AI finds patterns within material to identify common phenotypes, while pharmaceutical companies use that information to develop drugs targeted to the specific need.

Palo Alto, California-based Endpoint Health is one player in this space looking to tap the potential machine learning has for precision medicine. Today, it announced it has received $52 million series A equity and debt financing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Technology
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Katie Couric Talks Colon Cancer, Health Equity And AI
5 tips on AI adoption from a frontline physician champion
Survey of Oncologists Finds Agreement, Concerns Over AI Use

Share This Article